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Objectives. To compare percutaneous transluminal coronary
angioplasty (PTCA) and stent implantation with respect to the
long-term changes they induce in the newly formed endothelium
in porcine coronary arteries by studying both morphological and
functional parameters of the endothelium at 2 weeks and 3
months after intervention.
Background. Problems affecting PTCA or stent implantation
have been overcome to a large extent by means of better tech-
niques and the availability of new drugs. Late problems, however,
still exist in that restenosis affects a large number of patients.
With an increasing number of patients being treated with stents,
the problem of in-stent restenosis is of even greater concern, as
this seems difficult to treat. A functional endothelial lining is
thought to be important in controlling the growth of the underly-
ing vascular tissue. We hypothesized that the enhanced neointi-
mal hyperplasia observed after stenting is associated with a more
pronounced and prolonged endothelial dysfunction.
Methods. Arteries were analyzed using a dye-exclusion test and
planimetry of permeable areas. Thereafter, the arteries were
processed for light and scanning electron microscopy for assess-
ment of morphology and proliferative response.
Results. Leakage of the endothelium for molecules such as
Evans blue-albumin as well as prolonged endothelial proliferation
is observed as late as 3 months after the intervention, and is more
pronounced after stenting. Permeability is associated with distinct
morphologic characteristics: endothelial retraction, the expres-
sion of surface folds, and the adhesion of leukocytes.
Conclusions. Stenting especially decreases long-term vascular
integrity with respect to permeability and endothelial prolifera-
tion, and is associated with distinct morphologic characteristics.
(J Am Coll Cardiol 1998;32:1109–17)
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Problems affecting percutaneous transluminal coronary angio-
plasty (PTCA) or stent implantation such as acute closure,
stent thrombosis, or bleeding complications due to the strin-
gent anticoagulation protocols from the early days of stent use
have been overcome to a large extent by means of better
techniques and the availability of new drugs (1–4). Late
problems, however, still exist in that restenosis affects approx-
imately 15–20% of patients after primary stenting and 30–50%
after PTCA alone. With an increasing number of patients
being treated with stents (up to 50%), the problem of in-stent
restenosis is of even greater concern as this seems difficult to
treat.
Every intervention aimed at increasing lumen size inevita-
bly leads to damage of the vessel wall. The subsequent healing
response, necessary to pacify the inflicted wound, triggers the
growth of a neointimal thickening (NI). Excessive growth of
this NI is only one of the contributors to restenosis after
PTCA, but is likely the sole responsible factor when dealing
with in-stent restenosis. PTCA mechanically damages the
endothelial cells and induces endothelial dysfunction that
persists for several weeks both in the laboratory animal and in
patients (5–7). A functional endothelial lining is important in
controlling the growth of the underlying vascular tissue (8),
and it may well be that the enhanced neointimal hyperplasia
observed after stenting is associated with a more pronounced
and prolonged period of endothelial dysfunction.
The objective of the present study was, therefore, to
compare PTCA and stent implantation with respect to the
long-term changes they induce in the newly formed endothe-
lium in porcine coronary arteries. We therefore studied both
morphological (as assessed by general pathology, morphome-
try, histochemistry, electron microscopy [EM]) and functional
parameters of the endothelium (barrier function and prolifer-
ative status).
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Methods
Animal care. Experiments were performed under the reg-
ulations of the animal care committee of the Erasmus Univer-
sity Rotterdam and in accordance with the “Guide for the Care
and Use of Laboratory Animals” (9).
Animal preparation. Experiments were performed in
Yorkshire pigs (25–30 kg; HVC). After an overnight fast, the
animals were sedated with 20 mg/kg ketamine hydrochloride.
After induction of anesthesia with thiopental (12 mg/kg) and
after endotracheal intubation, the pigs were connected to a
ventilator that administered a mixture of oxygen and nitrous
oxide (1:2 [vol/vol]). Anesthesia was maintained with 0.5–
2.5 vol% isoflurane. Antibiotic prophylaxis was administered
by an intramuscular injection of 1,000 mg of a mixture of
procaine penicillin-G and benzathine penicillin-G.
Under sterile conditions, an arteriotomy of the left carotid
artery was performed and a 9-F introduction sheath was
placed. Then 10,000 IU heparin sodium were administered
followed by left coronary angiography using the nonionic
contrast agent iopamidol (Iopamiro 370) after intracoronary
administration of 1 mg isosorbide dinitrate.
Coronary interventions. From the angiograms (analyzed
on-line using a quantitative coronary angiography analysis
system), arterial segments of 2.5–3.5 mm in diameter were
selected in the left anterior descending and/or left circumflex
coronary arteries. Typically, balloon sizes were chosen
0.2–0.5 mm larger than the recipient artery. The stents (PS
153, Palmaz-Schatz Coronary Stent; JJIS, and Wiktor stent;
Medtronic) were placed as described before (10,11). PTCA
was performed in a similar way, using identical inflation
parameters. After repeat angiography of the treated coronary
arteries, the guiding catheter and the introducer sheath were
removed, the arteriotomy was repaired, and the skin was
closed in two layers. The animals were then allowed to recover
from anesthesia.
Experimental groups and follow-up. Interventions were
performed in four groups of animals, as shown in Table 1. In
groups 1 and 2 (a subset of animals from a previously published
study [10]) the animals received a Palmaz-Schatz stent only
and were followed for 4 and 12 weeks, respectively, to assess:
1) the “molecular window,” i.e., to which extent the barrier
function of the endothelial lining was impaired, and 2) whether
this “window” of permeability changed in time. In groups 3 and
4, both PTCA and stent implantation were performed in each
animal. These animals were followed for 2 and 12 weeks to
assess the morphologic determinants correlating with the
impaired barrier both in morphologically immature and ma-
ture endothelium, and to study differences between the two
types of intervention.
Assessment of cell proliferation. To assess the proliferative
response to stent implantation and PTCA in comparison with
control coronary arteries, five animals each in groups 3A, 3B,
4A, and 4B were given three intramuscular injections of BrdU
(Sigma Chemical Co.) at 100, 50, and 50 mg/kg at 8-h intervals,
starting 24 h before sacrifice. Using light microscopy (LM), the
total number and number of BrdU-positive cells were counted
for each section in several high-power fields both proximal and
distal in the treated arteries. The right coronary artery served
as a control.
Assessment of intimal permeability at follow-up. In this
test (Fig. 1, dye-exclusion test) Evans blue (EB) (Sigma
Chemical Co.) was used in two configurations (12,13).
EB-albumin. To subject the arteries to the large molecular
marker (70 kD), 300 mL of EB in saline (0.3% [wt/vol]) was
administered intravenously, to allow for EB binding to albu-
min. The infusion was given for 30 min, and then 1 h was
allowed for recirculation of the EB-albumin complex.
Binding control. During and after the EB infusion, arterial
blood samples were taken, proteins precipitated with tri-
chloric acid (final concentration 20%), and then spun down to
check the supernatant for unbound dye.
EB-saline. To subject the arteries to the small molecular
marker (1 kD), 300 mL of EB in saline (0.3% [wt/vol]) was
administered directly into the coronary circulation after a
saline flush. After completion of the EB infusions, the coro-
nary arteries were flushed with approximately 300 mL saline
Abbreviations and Acronyms
BrdU 5 bromodeoxy uridine
EB 5 Evans blue
EM 5 electron microscopy
LM 5 light microscopy
NI 5 neointimal thickening
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Study Groups
Group Intervention Follow-up n Molecular Weight Study Objective
1 Palmaz-Schatz stent 4 weeks 10 1 and 70 kD Window of permeability
2 Palmaz-Schatz stent 12 weeks 10 1 and 70 kD Window of permeability
3A Wiktor stent 2 weeks 9 70 kD Morphologic determinants
3B PTCA 2 weeks 9 70 kD Morphologic determinants
4A Wiktor stent 12 weeks 5 70 kD Morphologic determinants
4B PTCA 12 weeks 5 70 kD Morphologic determinants
n 5 number of arteries.
1110 VAN BEUSEKOM ET AL. JACC Vol. 32, No. 4
CORONARY ANGIOPLASTY AND ENDOTHELIAL DYSFUNCTION October 1998:1109–17
before pressure fixation in situ (approximately 100 mm Hg)
with 500 mL 4% buffered formaldehyde. Then the heart was
excised, and the treated and control coronary arteries (not
treated with balloon or stent) were dissected from the epicar-
dial surface.
Macroscopic assessment. The excised treated and control
coronary arteries were opened longitudinally and checked
under a dissection microscope for penetration of the blue dye.
The arteries were documented on film and used for planimet-
ric analysis of the permeable areas. Thereafter, both proximal
and distal areas of the specimen were divided for EM and LM.
Routine histology. To check for abnormal vascular reac-
tions to the interventions and for a general assessment of the
histological appearance, all specimens were processed for
routine histology as described before (10). Sections were
stained with hematoxylin-eosin as a routine stain and resorcin-
fuchsin as a collagen and elastin stain.
Histochemistry. Lectin- and immunocytochemistry. This
was performed to confirm the identity of the endothelium and
smooth muscle cells as described before (14).
Detection of BrdU incorporation. After acid DNA denatur-
ation and elimination of endogenous tissue peroxidase activity,
rehydrated paraffin sections were exposed to mouse anti–BrdU
antibody (Becton Dickinson & Co.), dilution 1:80, to detect
BrdU-positive cells. As a second antibody, HRP-labeled rabbit
anti–mouse antibody (Dakopatts) was used, with 670 mg/ml Di
Amino Benzidine (Sigma Chemical Co.) in phosphate-buffered
saline as a detecting reagent.
Morphometry. Intimal and medial thickness was deter-
mined along the length of the treated arterial segments. A
distinction was made between intimal and medial thickness
within and outside the PTCA lesion area and the media
underneath or between the stent struts. Data were analyzed
using elastin-stained sections and assessed on a microscopy
image analysis system (Impak C, Clemex vision Image analysis
system; Clemex Technologies Inc.) as described before (11). In
addition, lesion length was determined in the arteries treated
with PTCA, which was defined as the percentage of the
internal elastic lamina containing discontinuities or associated
with an intimal and/or medial thickening (15).
Scanning and transmission EM. To study endothelial mor-
phology (scanning EM) and to assess endothelial cell-cell
contact (transmission EM), selected tissues were fixed with
2.5% glutaraldehyde in 0.15 M cacodylate buffer, postfixed
with 0.1 M cacodylate buffer containing 1% OsO4 and 50 mM
ferricyanide (K3[Fe{CN}6]), and further processed as de-
scribed before (18). Specimens were examined in a JSM25
scanning electron microscope (Jeol Ltd.) and a CM100 trans-
mission microscope (Philips).
Statistical analysis. Analysis was performed using Sigma-
stat (versions 1.0 and 2.0, Jandel Scientific). Data are given as
mean 6 standard deviation. Morphometry was analyzed with a
Figure 1. EB can be administered both intravenously and intracoro-
narily. Intravenous administration results in the spontaneous binding
of EB to albumin, and subjection of the arterial wall to the 70-kD large
complex. Intracoronary administration after a saline flush to remove
serum proteins results in subjection of the arterial wall to the smaller
1-kD molecule. Blue staining of the arterial wall indicates a breach in
the luminal barrier.
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one-way ANOVA, the planimetry and angiography with a
one-way repeated measures ANOVA, and followed by an
all-pairwise comparison in case of statistical significance using
a Student Neuman Keuls or Tukey test. A p value of ,0.05 was
considered statistically significant.
Results
Procedural outcome. A total of 39 animals were enrolled in
the study. In group 3, one animal died suddenly within 1 h after
the procedure due to stent thrombosis. In group 4, four
animals died: one animal died during the procedure due to
ventricular fibrillation, one died within a few hours after the
procedure due to stent migration and subsequent stent throm-
bosis, one animal due to respiratory problems during recovery
from anaesthesia, and one animal died at 3 weeks after the
procedure ex causa ignota (not stent related). The remaining
34 animals were used for analysis, as summarized in Table 1.
Quantitative angiographic measurements are shown in Table
2. Quantitative coronary angiography (QCA) confirmed that
all stent and balloon sizes closely matched coronary artery
vessel size with a balloon-artery ratio between 0.95 and 1.1.
Intimal permeability. Binding control confirmed that com-
plete binding of EB to the albumin was achieved.
The “window” of permeability (groups 1 and 2). Macroscopy
(Fig. 2A and B) revealed that both the 1- and 70-kD markers
were able to stain the vessel wall at 4 as well as at 12 weeks post
stenting. This indicates that there is a wide window of perme-
ability that does not change during the first 3 months.
The “extent” of permeability (all groups). Except for occa-
sional small areas distal to side branches, where the endothe-
lium is often subject to hemodynamic stress, the control
arteries did not reveal staining (Fig. 2A). Both stent- and
balloon-treated arteries, however, did reveal a distinct staining
of the vessel wall (Fig. 2B–D). In the stented arteries staining
of the intima was generally observed over the stent wires, while
between the stent struts a much lower level of staining was seen
(Fig. 2B and C). Both the Wiktor stent and the Palmaz-Schatz
stent, however, revealed a specific staining pattern. In the
Palmaz Schatz stent staining was seen over the stent struts in
the area of the stent ends and in the area of the coupler (Fig.
2B), while in the Wiktor stents staining was observed over the
wire along the whole length of the stent (Fig. 2C). These
patterns did not change during the observation period. In
group 3B (2 weeks after PTCA alone) there were also areas
that revealed staining albeit less prominently (Fig. 2D). In
group 4B (12 weeks after PTCA) the pattern was the same but
the staining intensity was less.
Planimetry. Planimetry of the area permeable to EB at 2
weeks showed that the percentage was 35.4 6 19.7% for the
stented arteries (p , 0.05 vs balloon and control), 10.1 6 6.8%
for the PTCA treated arteries, and 2.5 6 2.2% for the control
arteries.
Electron microscopy and the endothelial barrier function.
Both scanning and transmission EM were performed on
groups 3 and 4. It confirmed that, in contrast to normal
endothelium (Fig. 3A), at 2 weeks after either stent implanta-
tion or PTCA the endothelial covering was still incomplete.
The areas covering the stent struts especially showed missing
cells, often in association with adhesion of leukocytes and
platelets. These areas were highly permeable to the EB dye.
The more diffusely permeable areas were characterized by an
endothelial layer where the cells appeared “retracted” (Fig.
3B). Transmission EM showed small or nonexistent intercel-
lular junctional complexes (Fig. 3C) in the areas with retracted
cells. Twelve weeks after the interventions, scanning EM
showed that the endothelial covering was complete in all
groups, and transmission EM now showed more extensive
junctional complexes even with tight junctions (Fig. 3D).
Permeability was now associated with a different phenomenon,
namely an endothelial layer with adhesion of leukocytes with a
rounded morphology that were also often seen penetrating the
endothelium as well as surface folds (Fig. 3E), which indicates
an increased endocytotic activity, although endothelial retrac-
tion was still observed occasionally.
Morphometry and assessment of cell proliferation. Mor-
phometric analysis is summarized in Table 3. At 2 weeks after
stenting (group 3A) there is a trend (p . 0.05) toward a larger
NI over the stent struts than after PTCA at the site of the
lesion (group 3B). At 12 weeks both the Wiktor stent (group
4A) and the Palmaz-Schatz stent (group 2) do induce a
statistically significant larger NI than after PTCA. Also, the
Wiktor stent induces a significantly more pronounced NI as
compared with the Palmaz-Schatz stent. Morphometric analy-
sis of the medial layers show that the stents significantly
impress the media, whereas at the site of the PTCA lesion the
media has thickened. At 4 and 12 weeks (groups 1, 2, and 4A)
the media has thickened between the stent struts and is now
Table 2. QCA Assessment of Arterial and Balloon Diameter at the Site of Intervention
Group Pre Balloon Ratio Post Fu
1 (n 5 10) 3.05 6 0.28 2.98 6 0.38 0.95 6 0.07 3.06 6 0.33 2.37 6 0.39
2 (n 5 10) 3.11 6 0.21 3.03 6 0.30 0.97 6 0.06 3.02 6 0.17 3.12 6 0.27
3A (n 5 9) 2.87 6 0.27 3.02 6 0.41 1.02 6 0.09 2.74 6 0.29 2.65 6 0.28
3B (n 5 9) 2.95 6 0.31 2.85 6 0.32 0.95 6 0.05 2.66 6 0.34 2.79 6 0.48
4A (n 5 5) 2.61 6 0.46 2.92 6 0.39 1.08 6 0.06 2.67 6 0.30 2.80 6 0.25
4B (n 5 5) 2.58 6 0.25 2.65 6 0.42 1.04 6 0.06 2.28 6 0.28 3.08 6 0.42
Data are in mm and given as mean 6 SD. Pre, Post, Fu: mean coronary lumen diameter at the site of intervention before, directly after, and at follow-up,
respectively. Balloon: mean diameter of the contrast filled balloon during maximal inflation. Ratio: balloon to artery ratio.
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similar to the lesion area in the balloon-treated arteries at 2
and 12 weeks.
For assessment of cell proliferation, the BrdU-positive and
total number of cells were counted in several sections. For each
artery this amounted to 200–400 endothelial cells; 200–400
(balloon group) and 1500–5500 (stent group) intimal cells;
1000–4000 medial and adventitial cells. The percentage of
BrdU incorporation is summarized in Table 4, and shows that
at 2 weeks after intervention the stent (group 3A) induced a
higher percentage of BrdU incorporation as compared with
PTCA in all tissue layers (p , 0.05). In the PTCA vessels (both
lesion area and nonlesion area) there was a trend (p . 0.05)
toward a higher percent proliferating cells as compared with
control (not injured) values. Twelve weeks after intervention
the levels of BrdU incorporation had decreased in all groups.
Only the endothelium overlying the stent struts was still
significantly higher as compared with control values (4.8 6 2%;
p , 0.05).
Microscopy. There were no adverse or unexpected vascular
reactions to the interventions as performed in groups 1–4, and
in general the tissue response was as described before (10,11).
In short, the stented arteries in groups 1, 2, and 4 were covered
by a variable intimal thickness consisting of smooth muscle
cells in a collagenous matrix and covered by endothelium.
Inflammatory reactions were limited for groups 1 and 2. In
group 4A, there were areas where the stent strut lacerated the
media, a phenomenon associated with a diffuse inflammatory
response. At 2 weeks (group 3A), the stent was embedded in a
mass of organizing thrombus, containing leukocytes and mac-
rophage giant cells, and was covered by an incomplete layer
of endothelial cells. There was medial hyperplasia (medial
thickening and longitudinal orientation of smooth muscle
cells) in association with BrdU incorporation between the
stent struts.
PTCA. At 2 weeks after PTCA (group 3B), there were
focal areas with a limited amount of neointima, which con-
sisted of smooth muscle cells in a collagenous matrix. In these
areas we observed fragmentation of the Lamina Elastica
Interna (LEI) and significant medial hyperplasia in association
with incorporation of BrdU (Fig. 4A). These lesions encom-
passed approximately 30% of the measured circumference.
The endothelial covering (as confirmed by lectin histochemis-
Figure 2. Macroscopy of the dye-exclusion test. A, Control right
coronary artery, shows a clean surface with occasional small blue areas.
B, Group 2, Palmaz-Schatz stent, 1 kD. For both molecular weights,
blue staining is found mainly at the stent ends and in the area of the
coupler (arrows). C, Group 3A Wiktor stent. Blue staining is seen
especially in the region of the intimal tissue covering the stent struts
(arrows). D, Group 3B, PTCA. Randomly stained areas (arrows) are
found in the arterial segment treated with PTCA and are more
apparent and intense in group 3B than 4B.
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try) was incomplete and had a variable morphology. At 12
weeks after PTCA (group 4B), there was still a limited amount
of intimal hyperplasia. Although the media was still thickened
in these areas and the lesions still encompassed approximately
30% of the measured circumference, there was no incorpora-
tion of BrdU, nor a clear fragmentation of the LEI. On the
contrary, we often observed an additional internal elastic mem-
brane under the newly formed endothelium (Fig. 4B). The
adventitia was unremarkable.
Discussion
In contrast to restenosis after PTCA, which is dictated both
by constrictive remodeling and tissue growth (16,17), resteno-
Figure 3. EM of groups 3 and 4. A, Scanning EM of a nonblue area
showing normal endothelium. B, Endothelial cell retraction at 2 weeks
after stenting as illustrated by scanning EM, shows fingerlike projec-
tions between adjacent endothelial cells (arrowhead). Some have
broken during critical point drying (asterisk). C, Transmission EM at
2 weeks after stenting shows loose junctions (arrow) between adjacent
endothelial cells. D, At 12 weeks after stenting, transmission EM shows
tight junctions (arrow). E, The permeable areas in the endothelium at
12 weeks after stenting are characterized by surface folds as observed
with transmission EM (arrow). N 5 nucleus.
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sis after stenting is the result of tissue growth alone. With
increasing numbers of patients being treated with stents (up to
50%), the problem of in-stent restenosis is becoming more and
more of a problem, as this seems more resistant to effective
treatment.
Vascular dysfunction and in particular endothelial dysfunc-
tion has been described after PTCA both in humans and
animals (5–8). As one of the first changes in the etiology of
atherosclerosis, endothelial dysfunction might also be involved
in the ongoing tissue growth after angioplasty procedures
(8,18). The aim of our study, therefore, was to investigate
endothelial function after stenting and compare this with
PTCA alone by assessing both morphologic and functional
parameters.
The main finding in our study is that both PTCA and stent
implantation result in an impairment of the vascular barrier
function at least up to 3 months after the procedure as
evidenced by the uptake of the EB dye. This loss of barrier
function is more pronounced after stenting than after PTCA,
and showed a stent-specific pattern. This breach was charac-
terized by specific endothelial morphologic correlates: in the
early phase by incomplete endothelialization and endothelial
retraction or loose intercellular connections. The late phase
was characterized by the expression of surface folds and the
adhesion of leukocytes. Both phenomena were also observed
in stented human vein grafts (19).
Transport routes across the endothelial lining. The extrav-
asation of (macro)molecules, such as EB bound to albumin,
proceeds mainly by two routes. One is through diffusion via the
cellular junctions, i.e., paracellular exchange (20,21), and the
other is by vesicle-mediated transport, i.e., transcellular trans-
port (22).
Paracellular exchange is morphologically associated with
small interendothelial gaps caused by contractile forces in the
cell and by disintegration of cell–cell junctions (23,24). This
process is regulated by actin fibers, which are connected to
other proteins anchoring the cells to their neighbors and to the
extracellular matrix (25,26). Vasoactive agents and thrombin
can affect the integrity of the endothelium through phosphor-
ylation of specific target proteins. As a consequence, actin
reorganization may occur through RhoA– and protein kinase
C–activated pathways. The interaction between actin and
nonmuscle myosin, activated by phosphorylation of the myosin
light chain, subsequently causes contraction and gap formation
(24,27). Interaction of leukocytes with the endothelium, which
is enhanced by inflammatory mediators, can enhance this
response (28). In addition to the effects of vasoactive agents,
paracellular permeability can also be enhanced by the lingering
proliferative response of the endothelium itself. Cell retraction
associated with cell mitosis causes paracellular gaps in arterial
endothelial cells in vivo (29). Because cell division is found
until at least 3 months after intervention, particularly in areas
overlying stent struts, it may contribute to the observed leakage
of EB-albumin complex. Both endothelial barrier function and
proliferation are under control of the extracellular matrix.
Remodeling of the extracellular matrix by proteases can re-
Table 3. Morphometry
Group
NI
Media
Stent or PTCA Lesion
Underneath PTCA Lesion
or Stent Struts
Between Stent Struts or
PTCA Lesion/Nonlesion
1 (stent) 259 6 104*3a,3b,4b 99 6 22 187 6 28*3a,3b,4a
2 (stent) 192.1 6 63.3*3b,4b 109.8 6 21.6 184.3 6 16.3*3a,3b,4b
3A (stent) 114 6 60 71 6 40 122 6 26
3B (PTCA) 33 6 11 221 6 77*1,2,3a,4a 119 6 15
4A (stent) 305 6 155*3a,3b,4b 73 6 29 182 6 29*3a,3b,4b
4B (PTCA) 19 6 12 181 6 53*1,3a,4a 128 6 33
*p , 0.05 vs group . . ., ANOVA-Tukey test. Data are in mm and given as mean 6 SD. The NI was measured on top
of the stent struts and compared with the NI in the PTCA lesion. Media thickness was measured underneath and between
the stent struts and compared with the media thickness in the PTCA lesion and nonlesion area.
Table 4. Assessment of Cell Proliferation (% BrdU-Positive Cells)
Group (n) EC NI M ADV
Control (n 5 6) 0.4 6 0.1 Nonexistent 0.9 6 0.1 1.07 6 0.1
3A (n 5 6) 22.2 6 7.5* 18.8 6 2.7* 6.5 6 1.2* 7.9 6 2.1*
3B: lesion area (n 5 5) 5 6 3.8 6.14 6 8.2 2.66 6 2.62 3.98 6 4.41
3B: non-lesion area (n 5 6) 2.64 6 2.65 Nonexistent 0.86 6 0.43 0.98 6 0.78
4A (n 5 5) 3.5 6 1.1 2.7 6 1.1 1.6 6 1 2.3 6 1.1
4B: lesion area (n 5 4) 1.3 6 1.5 1.2 6 0.91 1.5 6 0.67 0.75 6 0.76
4B: non-lesion area (n 5 5) 0.3 6 0.6 Nonexistent 0.99 6 0.91 0.64 6 0.54
EC 5 endothelial cells; M 5 media; ADV 5 adventitia. *p , 0.05 vs. all groups, ANOVA-student neuman keuls test.
Data are mean 6 SEM.
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duce the firm interaction between cell and matrix. This reduc-
tion may enhance the efficacy of endothelial permeability-
increasing agents (25,30).
Transcellular (vesicle-mediated) transport is the second
major route for macromolecular exchange across the endothe-
lial lining. Both paracellular and transcellular exchange of
albumin are increased by VEGF (31), a growth factor that is
induced in injured arteries (32,33). Further studies have to
elucidate whether and for how long VEGF is induced in
stented coronary arteries.
In vivo (34,23) and in vitro studies (35,36) have shown that
an increase in endothelial permeability in the microcirculation
can be reversed by exposing the endothelium to cAMP-
elevating agents. In preliminary experiments we found that
intracoronary administration of 1 mM dibutyryl-cAMP within
10 min indeed partly normalizes the barrier function in areas of
increased permeability covering and adjacent to the implanted
stents (Fig. 5). The areas that were permeable because of
missing endothelial cells were not affected by this treatment. A
reduced cellular cAMP concentration/content has been re-
ported in arterial cells in intimal tissue affected by atheroscle-
rosis (37). However, it remains to be established whether this
also occurs in the new layer of endothelial cells in stented
arteries. The reduction in endothelial permeability by eleva-
tion of cellular cAMP levels indicates that a major part of the
leakage of EB-albumin occurs via impaired junctional com-
plexes between endothelial cells. However, the current state of
knowledge does not permit exclusion of a minor contribution
by vesicular transport.
Permeability after PTCA takes place preferentially in the
area designated as the lesion area containing intimal hyperpla-
sia. Clearly these are areas where the endothelium is attached
to a changed basement membrane or extracellular matrix. In
the stented segments, the intima covering the stent struts is
also constantly changing during the process of scar maturation,
which might explain permeability over the stent struts in
general but not the differences between stent designs. Whereas
the Wiktor stent shows preferential dye-uptake over all of the
stent wires throughout the whole stent, the Palmaz-Schatz
stent shows dye-uptake preferentially over the stent struts at
both stent extremities and over the area of the coupler. It
would seem that these specific patterns of dye-uptake are a
reflection of the design of the stent. The Wiktor stent has a
more open design than the Palmaz-Schatz stent, and as
permeability seems to occur in areas where theoretically
movement between the tissue and the stent struts may occur,
Figure 4. LM. A, Group 3B. At 2 weeks after PTCA, focal lesions can
be found with BrdU incorporation (arrow), especially underneath the
endothelial lining but also elsewhere in the intima (i) and media (m).
HRP-DAB with hematoxylin counterstain. Bar 5 50 mm. B, Group 4B.
At 12 weeks after PTCA, there is still a limited NI, sometimes with an
additional elastic membrane underneath the endothelium (arrow).
Resorcin-Fuchsin, i 5 intima, m 5 media. Bar 5 50 mm.
Figure 5. Macroscopy c-AMP–treated arteries. Macroscopy of the
coronary arteries at 2 weeks after implantation of a Wiktor stent.
While a “control” artery (A) was not exposed to db-c-AMP, but only to
EB, the c-AMP-treated artery was first exposed to 1 mM db-c-AMP
and then to EB with a molecular weight of 1 kD (B), showing an
improvement especially in the areas between the stent struts.
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this may be a factor influencing the chronic vascular irritation
by the stents. From the literature it is known that mechanical
instability of healing bone fractures, for instance, affects the
composition of the extracellular matrix with respect to the level
of sulfate incorporation in the glycosaminoglycans (38). If
these processes also take place in the vessel wall it would
certainly influence endothelial function and permeability.
Conclusions. This study indicates that especially stenting
decreases long-term vascular integrity with respect to perme-
ability. Leakage is observed with molecules such as EB and
EB-albumin complex, and is associated with prolonged endo-
thelial proliferation and distinct morphologic characteristics
such as endothelial retraction, the expression of surface folds,
and the adhesion of leukocytes.
The authors wish to thank Robert H. van Bremen for his technical assistance and
Johnson & Johnson Interventional and Medtronic Inc. for supplying the stents.
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